Accuracy of fine needle aspiration biopsy to diagnose lymphadenopathy in Dr.Sardjito General Hospital, Yogyakarta, Indonesia by Dwianingsih, Ery Kus et al.
J Med Sci, Volume 52, Number 1, 2020 January: 48-59
48*corresponding author: ery_malueka@ugm.ac.id
Journal of the Medical Sciences
(Berkala Ilmu Kedokteran)
Volume 52, Number 1, 2020; 48-59 
http://dx.doi.org/10.19106/JMedSci005201202006
Submited: 2019-04-25
Accepted : 2019-11-13
Keywords: 
FNAB; 
malignant; 
lymphadenopathy;
Non-Hodgkin lymphoma; 
Hodgkin lymphoma;
Accuracy of fine needle aspiration biopsy to diagnose 
lymphadenopathy in Dr.Sardjito General Hospital, 
Yogyakarta, Indonesia
Ery Kus Dwianingsih1*, Claudia Priska3, Andre Stefanus Panggabean3, Linda Pratiwi3, Naomi 
Yoshuantari1, Mardiah Suci Hardianti2, Indrawati1
1Department of Anatomical Pathology, 2Department of Internal Medicine, 3Faculty of Medicine, 
Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
ABSTRACT
Lymphadenopathy is a non-specific enlargement of lymph nodes which may 
be caused by infection, cancer, or autoimmune disease. To date, only a few 
studies reported the diagnostic value of fine-needle aspiration biopsy (FNAB) in 
lymphadenopathy. This study was performed to evaluate diagnostic reliability 
of FNAB for benign and malignant lymphadenopathy. This was a retrospective 
cross-sectional study. The obtained data were statistically analyzed for its 
sensitivity, specificity, and accuracy. Out of 126 collected FNAB cases with 
histopathological confirmed results in Dr. Sardjito General Hospital, Yogyakarta, 
85 (67.4%) were malignant lymphadenopathy, consisting of 42 metastatic tumor 
cases, 38 non-Hodgkin lymphoma (NHL) cases, and 4 Hodgkin lymphoma (HL) 
cases.The overall diagnostic sensitivity, specificity, and accuracy of FNAB in 
lymphadenopathy was 85.88, 70.73, and 80.95%, respectively. In diagnosing 
metastatic tumors, FNAB had sensitivity of 83.33%; specificity of 89.28%; and 
accuracy of 87.3%. The sensitivity, specificity, and accuracy of FNAB in diagnosing 
NHL was 60.52, 94.31, and 84.12%, respectively. FNAB had a sensitivity of 25%, 
specificity of 95,90%, and accuracy of 93.65% to diagnose HL. Meanwhile, the 
accuracy of FNAB in diagnosing malignancies in generalized lymphadenopathy, 
head-neck lymphadenopathy, and inguinal lymphadenopathy was 90.90; 81.39 
and 44.44%, respectively. In conclusion,FNAB has moderate diagnostic value in 
diagnosing overall malignant lymphadenopathy, including metastatic tumors. 
FNAB also has some limitations in diagnosing NHL and HL, with sensitivity 
less than 70% for both diseases. However, it has high accuracy to diagnose 
generalized lymphadenopathy.
ABSTRAK
Limfadenopati adalah pembesaran kelenjar getah bening non-spesifik yang 
mungkin disebabkan oleh infeksi, kanker, atau penyakit autoimun. Sampai 
saat ini, hanya beberapa penelitian yang melaporkan nilai diagnostik biopsi 
aspirasi jarum halus/fine-needle aspiration biopsi (FNAB) pada limfadenopati. 
Penelitian ini dilakukan untuk memberikan diagnostik FNAB yang teruji 
pada limfadenopati jinak dan ganas. Ini adalah penelitian potong lintang 
retrospektif. Data yang diperoleh dianalisis secara statistik untuk sensitivitas, 
spesifisitas, dan akurasinya. Dari 126 kasus FNAB yang dikumpulkan dengan 
hasil histopatologis dikonfirmasi di Rumah Sakit Umum Pusat Dr. Sardjito 
Yogyakarta, 85 (67,4%) adalah limfadenopati ganas, yang terdiri dari 42 kasus 
tumor metastasis, 38 kasus non-Hodgkin lymphoma (NHL), dan 4 kasus Hodgkin 
lymphoma (HL). Sensitivitas diagnostik keseluruhan, spesifisitas, dan akurasi 
FNAB dalam limfadenopati berturut-turut adalah 85,88; 70,73 dan 80,95%. 
Dalam mendiagnosis tumor metastasis, FNAB memiliki sensitivitas 83,33%; 
spesifisitas 89,28%; dan akurasi 87,3%. Sensitivitas, spesifisitas, dan akurasi 
FNAB dalam mendiagnosis NHL berturut-turut adalah 60,52; 94,31 dan 84,12%. 
FNAB memiliki sensitivitas 25%; spesifisitas 95,90%; dan akurasi 93,65% untuk 
mendiagnosis HL. Sementara itu, akurasi FNAB dalam mendiagnosis keganasan 
pada limfadenopati umum, limfadenopati kepala-leher, dan limfadenopati 
inguinal masing-masing adalah 90,90; 81,39 dan 44,44%, masing-masing. Dapat 
disimpulkan, FNAB memiliki nilai diagnostik sedang dalam mendiagnosis 
limfadenopati ganas secara keseluruhan, termasuk tumor metastasis. FNAB 
juga memiliki beberapa keterbatasan dalam mendiagnosis NHL dan HL, dengan 
sensitivitas kurang dari 70% untuk kedua penyakit. Namun, ia memiliki akurasi 
tinggi untuk mendiagnosis limfadenopati generalisata.
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INTRODUCTION
Lymphadenopathy is defined as 
enlargement of lymph nodes, either 
caused by infiltration of inflammatory 
cells or invasion of neoplastic cells into 
lymph nodes. Lymphadenopathy lasting 
less than two weeks or more than one 
year without progressive increase in 
size shows a very low possibility of 
being neoplastic.1 Lymph nodes serve 
as an important part of the defense 
system of the human body that become 
secondarily involved in infectious 
diseases, neoplastic disorders, lipid 
storage diseases, endocrine disorders 
and in many other conditions such 
as sarcoidosis and histiocytosis.2 The 
prevalence of malignancy is considered 
to be quite low among all patients with 
lymphadenopathy.1
Tissue biopsy is the gold standard 
method to establish the etiology of 
lymphadenopathy, however fine 
needle aspiration biopsy (FNAB) has 
been reported as an approach to make 
initial diagnosis since it is less invasive, 
simpler, and cheaper. The FNAB method 
is applied by merely using a needle 
without the need of general anesthesia 
or complicated surgical procedures. It 
is considered as the easiest and fastest 
diagnostic modality to establish the 
diagnosis.3 Some studies reported 
that FNAB showed high accuracy in 
diagnosing neoplasia in many organs, 
such as thyroid, breast, soft tissue, bone, 
and lymph nodes.4-8 Sengupta reported 
that FNAB showed 90% sensitivity, 
100% specificity, and 98.88% accuracy 
in establishing diagnosis in thyroid 
nodules. Meta-analysis study of FNAB 
accuracy in breast cancer showed that 
the sensitivity and specificity were high, 
with 92.7 and 94.8%, respectively.5 FNAB 
sensitivity and specificity in inguinal 
lymph nodes were reported to be 91.7 
and 98.2%, respectively.8 However, the 
role of FNAB for initial diagnosis and 
sub-classification of primary lymphoid 
malignancy is still controversial. 
Cytological diagnosis in FNAB is almost 
always needed to be followed with tissue 
biopsy.9 FNAB is also reported useful to 
detect non-neoplastic lesions such as 
dermatopathic lymphadenopathy and 
other lymphadenopathy caused by HIV 
or tuberculosis.10-12 Diagnostic value of 
FNAB varied in many studies, affected 
by material adequacy criteria, inferior 
sampling techniques, errors in cytologic 
interpretation, and limitations of the 
procedure.13
This study was performed to evaluate 
diagnostic value of FNAB for benign 
and malignant lymphadenopathy in Dr. 
Sardjito General Hospital, Yogyakarta, 
Indonesia. This research will aid hospitals 
to evaluate pathologists’ performance in 
order to improve patient care.
MATERIALS AND METHODS
Subjects
This research was a retrospective 
cross-sectional study. Samples which 
fulfilled inclusion and exclusion criteria 
were collected from the Department 
of Anatomical Pathology, Dr. Sardjito 
General Hospital/Faculty of Medicine, 
Public Health and Nursing, Universitas 
Gadjah Mada, Yogyakarta, Indonesia, 
from January 2012 to December 2017 
without randomization (consecutive 
sampling). Patients  recruited for this 
study were patients with lymph node 
enlargement who underwent both 
FNAB and excision biopsy procedures 
so that the cytological findings could be 
confirmed with histopathological results 
as the gold standard of diagnosis. This 
study was approved by The Medical and 
Health Research Ethics Committee of 
Dr. Sardjito General Hospital/Faculty of 
Medicine, Public Health, and Nursing, 
Universitas Gadjah Mada, Yogyakarta.
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Protocol
All FNAB were blindly performed, 
without any imaging guide. 
Immunohistochemical and other 
molecular examination, such as clonality 
test, were not available for most of 
cases, so that they were not used as 
gold standard in this study. Patients 
with incomplete data were excluded 
from the study. The dependent variable 
was histopathological result of excision 
biopsy, and the independent variable 
was the cytopathological finding of 
FNAB. 
Statistical analysis
Data were presented as mean ± 
standard deviation (SD) or frequency 
or percentage and statistically analysis 
using SPSS and a 2x2 table to analyze the 
sensitivity, specificity, and accuracy.
RESULTS
Based on patients’ medical records 
from January 2012 to December 
2017, there were 1702 patients with 
lymphadenopathy who underwent the 
FNAB procedure, with 165 patients in 
2012, 253 patients in 2013, 391 patients in 
2014, 190 patients in 2015, 455 patients in 
2016, and 248 patients in 2017. There were 
only 126 patients who were confirmed by 
undergoingexcision biopsy, 17 patients 
in 2012, 19 patients in 2013, 30 patients 
in 2014, 15 patients in 2015, 32 patients 
in 2016, and 13 patients in 2017. TABLE 
1 demonstrated subject characteristics 
based on sex, age and predilection 
organs. Sixty-five subjects were male 
(51.5%) and the rest of the 61 subjects 
were female (48.5%). The average age 
in this study was 47.32±18.02 years old, 
and the youngest patient was 3 months 
old while the oldest patient was 78-year-
old. The highest incidence occurred at 
the40-59 year-old group (47.6%). The 
most common site of lymphadenopathy 
was head-neck in 85 patients (67.5%), 
followed by axilla (11.9%), generalized 
(8.7%), inguinal (7.1%), supraclavicular 
(4.0%) and abdominal (0.8%).
TABLE 1. Subject characteristics based on 
sex, age group and predilection, 
year 2012-2017
Characteristics Frequency %
Sex
•	 Male 65 51.5
•	 Female 61 48.5
Age
•	 0- ≤19 12 9.5
•	 20-≤39 21 16.6
•	 40 -≤59 60 47.6
•	 60-≤69 33 26.1
Predilection
•	 Head neck 85 67.5
•	 Abdominal 1 0.8
•	 Axilla 15 11.9
•	 Supraclavicular 5 4.0
•	 Inguinal 9 7.1
•	 Generalized 11 8.7
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FNAB findings were confirmed 
with histopathological results as shown 
in TABLE 2. Analysis of 126 cases 
showed that FNAB findings of 85 cases 
(67.4%) were malignant, and 41 cases 
(32.6%) were benign. Histopathological 
resultsalso revealed that 85 cases (67.4%) 
were malignant and 41 cases (32.6%) 
were benign. 
TABLE 2. FNAB results compared to histopathological results
Histopathology
Total
Malignant Benign
FNAB results
Malignant 73 12 85
Benign 12 29 41
The calculation of diagnostic value 
was performed based on data in TABLE 
2. Sensitivity of FNAB was 85.88% with 
specificity of 70.73%. positive predictive 
value (PPV) was 85.88%, while negative 
predictive value (NPV) was 70.73%. 
FNAB accuracy for lymphadenopathy 
was 80.95%.
TABLE 3. FNAB findings compared to histopathological results based on 
predilection area
Locations
Histopathology
Total
Malignant Benign
FNAB
Head and neck
Malignant 45 8 53
Benign 8 24 32
n 53 32 85
Abdominal
Malignant 1 0 1
Benign 0 0 0
n 1 0 1
Axilla
Malignant 12 0 12
Benign 2 1 3
n 14 1 15
Supraclavicular
Malignant 4 0 4
Benign 0 1 1
n 4 1 5
Inguinal
Malignant 3 3 6
Benign 2 1 3
n 5 4 9
Generalized
Malignant 8 1 9
Benign 0 2 2
n 8 3 11
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TABLE 4. The sensitivity, specificity, PPV, NPV, and accuracy of each region for 
FNAB compared to histopathology
Location Sensitivity Specificity PPV NPV Accuracy
Head and Neck 84.91 75 84.91 75 81.17
Abdominal* 100 - 100 - 100
Axilla 85.71 100 100 33.33 86.67
Supraclavicular 100 100 100 100 100
Inguinal 60 25 88.89 33.33 44.44
Generalized 100 66.67 88.89 100 90.91
PPV: positive predictive value; NPV: negative predictive value; * The 
specificity and NPV can’t be determined because the sample was only 1.
Based on predilection area, diagnostic 
value analysis of FNAB procedure was 
performed (TABLE 3 and 4). Generalized 
and supraclavicular lymphadenopathy 
FNABs have the highest sensitivity 
(100%), followed by axilla (85.71%) 
and head-neck lymphadenopathy 
(84.90%). The highest FNAB specificity 
was neck-head (75%), followed by 
generalization (66.67%) and inguinal 
lymphadenopathy (25%). The highest 
FNAB accuracy was in supraclavicular 
lymphadenopathy (100%), followed by 
generalized lymphadenopathy (90.90%), 
axilla (86.67%), head-neck (81.17%) and 
inguinal (44.44%) lymphadenopathy.
TABLE 5 showed cytological 
diagnosis (FNAB) compared with 
histopathological diagnosis (excision 
biopsy). Based on the diagnosis of 
Hodgkin lymphoma (HL), Non-Hodgkin 
lymphoma (NHL), and tumor metastasis, 
diagnostic value of FNAB was analyzed 
by comparing cytological diagnosis with 
histopathological result as gold standard. 
TABLE 5. Cytology (FNAB) diagnosis compared to histopathology diagnosis
FNAB Number Histopathology diagnosis Number
Reactive lymphoid 
hyperplasia
1 Reactive lymphoid hyperplasia 1
Lipoma 1 Non-specific chronic lymphadenitis 1
No Malignant Cell 5 Cavernous hemangioma 1
Tuberculous lymphadenitis 1
Angiomyolipoma 1
Chronic lymphadenitis 2
Granulomatous 
lymphadenitis
16 Tuberculous lymphadenitis 7
Non-specific chronic lymphadenitis 3
Hodgkin lymphoma 2
Non-Hodgkin lymphoma 3
Lymphangioma 1
Suppurative 
lymphadenitis
7 Granulomatous lymphadenitis 2
Tuberculous lymphadenitis 2
Non-specific lymphadenitis 1
Metastatic melanoma 1
Metastatic undifferentiated carcinoma 1
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Chronic lymphadenitis 12 Non-specific chronic lymphadenitis 3
Granulomatous lymphadenitis 1
Tuberculous lymphadenitis 1
Benign hemangiopericytoma 1
Non-Hodgkin lymphoma 4
Metastatic undifferentiated carcinoma 1
Metastatic ductal carcinoma 1
Lymphoma, 
undetermined type
6 Non-Hodgkin lymphoma 3
Chronic lymphadenitis 2
Tuberculous Lymphadenitis 1
Hodgkin lymphoma 6 Hodgkin lymphoma 1
Non-Hodgkin lymphoma 3
Chronic lymphadenitis 1
Metastatic undifferentiated carcinoma 1
Non-Hodgkin 
lymphoma
28 Non-Hodgkin lymphoma 23
Chronic lymphadenitis 1
Granulomatous lymphadenitis 2
Metastatic carcinoma 2
Metastatic 
undifferentiated 
carcinoma
11 Metastatic undifferentiated carcinoma 5
Hodgkin lymphoma 1
Non-Hodgkin lymphoma 2
Non-specific chronic lymphadenitis 2
Metastatic adenocarcinoma 1
Metastatic squamous 
cell carcinoma
4 Metastatic squamous cell carcinoma 4
Metastatic ductal 
carcinoma
11 Metastatic ductal carcinoma 10
Metastatic invasive mixed ductal-lobu-
lar carcinoma
1
Metastatic lobular 
carcinoma
4 Metastatic lobular carcinoma 3
Metastatic ductal carcinoma 1
Metastatic 
adenocarcinoma
7 Metastatic adenocarcinoma 3
Metastatic squamous cell carcinoma 1
Metastatic papillary carcinoma 2
Metastatic undifferentiated carcinoma 1
Metastatic melanoma 
malignancy
3 Metastatic melanoma 2
Non-specific chronic lymphadenitis 1
Metastatic follicular 
carcinoma
1 Metastatic ductal carcinoma 1
Metastatic small cell 
tumor
1 Metastatic small cell tumor 1
Malignant, 
undetermined type
2 Non-specific chronic lymphadenitis 1
Sinus histiocytosis 1
Total 126 Total 126
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Malignant cases revealed in this 
study were lymphoma, either HL and 
NHL subtype, and various types of 
metastatic cases that were summarized 
in TABLE 6 to 8. In diagnosing HL, FNAB 
showed very low sensitivity (25%), but 
high in specificity (95.90%) and accuracy 
(93.65%) (TABLE 5). In diagnosing 
NHL, FNAB showed low sensitivity 
(60.52%), but high in specificity (94.31%) 
and accuracy (84.12%) (TABLE 6). 
Interestingly, as demonstrated in TABLE 
7, FNAB showed high sensitivity (83.33%), 
specificity (89.28%) and accuracy (87.3%) 
to diagnose tumor metastasis in lymph 
node. Terminology of undetermined 
type of lymphoma in this study is used 
as a cytological term due to inability to 
differentiate lymphoma into its subtypes.
TABLE 6. FNAB results in diagnosing hodgkin 
lymphoma
Histopathology
Total
(+) (-)
FNAB
(+) 1 5 6
(-) 3 117 120
Total 4 122 126
TABLE 7. FNAB results in diagnosing non-
hodgkin lymphoma
Histopathology
Total
(+) (-)
FNAB
(+) 23 5 28
(-) 15 83 98
Total 38 88 126
TABLE 8. FNAB results in diagnosing tumor 
metastasis in lymph node
Histopathology
Total
(+) (-)
FNAB
(+) 35 9 44
(-) 7 75 82
Total 42 84 126
DISCUSSION
Despite the high number of 
FNAB lymphadenopathy cases, there 
were limited samples eligible to be 
included in this study since not all 
subjects, particularly benign cases, 
underwent excision biopsy for diagnosis 
confirmation. Few cases with excision 
biopsy were performed in other hospital 
(s), thus histopathological data was 
difficult to obtain.  Therefore, only 126 
subjects were included in this study. 
In this study, lymphadenopathy 
occurred almost evenly between females 
and males with ratio 1:1.06. This result 
is comparable with previous reports 
showing that males are more prone 
to have lymphadenopathy compared 
to females, with ratio of 1.5:1.14 Some 
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factors have been reported as the cause 
of gender disparity in malignancy, 
including sex hormones, genetic 
materials, environmental exposure, and 
epigenetic factors. Higher malignancy 
incidence in males was related to 
environmental and occupational 
exposure such as diet, smoking, and sun 
exposure.15 Immunological response in 
cancer is different in males and females 
due to x-linked gene expression and 
steroid hormones. Estrogen functions 
as immunomodulator by stimulating 
immune cells and decreasing cytokine 
production such as IL-6. High estrogen 
levels in females decrease susceptibility 
of infection. Thus, males have higher 
susceptibility for acquiring infections 
compared to females. This pattern may 
cause different disease incidences in 
males and females.15
Lymphadenopathy mostly occurred 
in the age groups 40-59 year old (47.6%), 
60-79 year old (26.1%), and 20-39 year 
old (16.6%)in this study. In a previous 
study, the highest case occurred at the 6th 
decade (18%) of age, followed by the 4th 
decade (16.8%) and 5th decade (15.9%).14 
Another study with 1022 patients showed 
a different pattern with the majority of 
the patients in the range of 21-50 years 
old.16
The most common site of 
lymphadenopathy was head-neck 
in 85 patients (67.5%), followed by 
axilla, generalized site, inguinal, 
supraclavicular, and abdominal regions. 
This study found similar results with 
previous studies, reporting that most of 
lymphadenopathy occurred localized, 
especially in the head-neck or cervical 
region.16-20
Sensitivity, specificity, and accuracy 
of lymphadenopathy FNAB in this study 
were moderate; 85.88%, 70.73%, and 
80.95% respectively. Previous study in 
233 research subjects, reported high 
sensitivity (94%), and specificity (99%) 
of lymphadenopathy FNAB.21 A study 
by Haquewith 81 cases showed that 
sensitivity and specificity of FNAB in 
lymph node were 82.76 and 97.92%, 
respectively.22
Based on location, FNAB sensitivity 
was the highest in generalized and 
supraclavicular lymphadenopathy, 
specificity was highest in head and 
neck lymphadenopathy, and the highest 
accuracy to detect malignancy was 
in generalized and supraclavicular 
lymphadenopathy. Location of lymph 
node enlargement may affect the 
diagnostic value of FNAB. Generalized 
lymphadenopathy has higher sensitivity 
and specificity since it is predictable that 
generalized lymphadenopathy is caused 
by serious infection, autoimmune 
disorders, and malignancy for example, 
lymphoma, leukemia, or metastasis. 
Head and neck lymph nodes are also a 
predictable common region of metastatic 
tumors of nasopharyngeal cancer.23 
Previous study conducted in 94 patients 
with head and neck lymphadenopathy 
reported that sensitivity, specificity, and 
accuracy of the study was 94.7, 89.3, 
and 92.9%, respectively.24 In contrast 
to previous report, a study of inguinal 
lymphadenopathy in 210 patients 
showed high sensitivity (91.7%) and 
specificity (98.2%).7 The low results of 
sensitivity, specificity, and accuracy of 
FNAB in inguinal lymphadenopathy 
in this study weremostly caused by the 
small sample size (11 cases). 
FNAB sensitivity to diagnose HL in 
this study is very low (25%). However, 
the specificity and accuracy were high, 
95.90 and 93.65%, respectively. Prasad 
et al.25 conducted a similar study on 1041 
subjects and the results showed that the 
sensitivity was 30% and the specificity 
was 98.6%. Limitation of FNAB in 
diagnosing HL was also reported by 
another study, where only 45% of 
subjects were diagnosed with HL  based 
on histopathological results.26
In this study, there were 3 false 
negative cases diagnosed as metastatic 
undifferentiated carcinoma (1 case) 
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and granulomatous lymphadenitis 
(2 cases). Three false positive cases 
were diagnosed as NHL in cytology 
examination, while the other two were 
diagnosed as chronic lymphadenitis and 
metastatic undifferentiated carcinoma. 
Granulomatous response, fibrosis and 
co-infection have been reported as 
confounding factors in diagnosing HL 
using FNAB.27
FNAB sensitivity to diagnose NHL 
was higher than HL (60.52%). Meanwhile, 
the specificity and accuracy were quite 
high, with 94.31 and 84.12%. Previous 
studyreported that sensitivity and 
specificity FNAB in NHL were higher, 
with 80.3 and 58.33%, respectively.25 
Another study reported that FNAB 
sensitivity was variable, from 0 to 100%, 
with average of 74%.28
In this study, there were 15 false 
negative cases, diagnosed as chronic 
lymphadenitis, granulomatous 
lymphadenitis, and metastatic 
undifferentiated carcinoma. Five 
false positive cases were chronic 
lymphadenitis, granulomatous 
lymphadenitis, and metastatic 
carcinoma identified as NHL. Cytology 
sample scontaining abundant histiocytes 
will be difficult to be distinguishedfrom 
granulomatous lesions since FNAB does 
not show tumor structure.13 Sensitivity 
and specificity of FNAB can be affected 
by many factors, for example, sample 
adequacy, superinfection accompanied 
by necrotic appearance, fibrosis, clinical 
and radiology information, pathologist 
experience in interpreting cytology 
specimen and special methods of 
staining.29
FNAB sensitivity, specificity, and 
accuracy for metastatic tumors were 
high, with 83.33, 89.28, and 87.3%, 
respectively. These results corresponded 
with previous studies, showing values 
consistently above 90%.25,30 In this study, 
there were 7 false negative cases, where 
metastatic carcinoma was diagnosed 
as chronic lymphadenitis, suppurative 
lymphadenitis, HL, and NHL. There 
were 9 false positive cases, identified 
as chronic lymphadenitis, NHL, and 
HL in histopathology examination. 
False negative results may occur in 
inadequate or unsatisfactory sampling 
due to difficult lymph node location, for 
example, deep inguinal lymph nodes.31 
In such cases, ancillary tools may be 
used to achieve better visualization. 
Anotherreporthas mentioned similar 
false positive cases such as in our study, 
HL, and reactive lymphoid hyperplasia, 
with the main reason of error was lack 
of information on clinical examination.24 
Insufficient sampling has been reported 
as another cause of false positive cases, 
along with the enlargement of reactive 
lymph node.32 False positive FNAB results 
may contribute to adverse consequences, 
depending to which diagnosis chosen.
Fluoroscopy, ultra-sonography (USG), or 
computerized tomography (CT) scan can 
be used to directly guide pathologists or 
radiologists to obtain samples from the 
proper location of the tumor.33 Some 
studies reported that imaging such as 
USG can increase accuracy of FNAB.18 In 
cases where pathologists found difficulty 
to distinguish malignant from benign 
lesions, immunostaining for lymphoma 
or metastatic tumors was helpful to 
establish the diagnosis.30
Diagnostic value variations of FNAB 
techniqueexisted in many previous 
studies. These are caused by several 
factors, including whether the collected 
material is sufficient during sampling 
or inferior sampling techniques. Some 
errors in cytologic interpretation can 
contribute to the variation of diagnostic 
value as well. Furthermore the 
complicated location of FNAB may also 
cause the limitations of the procedure 
so that imaging guided such as USG is 
needed.13
CONCLUSION
In this study, FNAB as a diagnostic 
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modality showed low to moderate 
value in diagnosing overall malignancy 
in lymphadenopathy cases, including 
metastatic tumors. It had several 
disadvantages in diagnosing NHL and 
HL with sensitivity less than 70%. 
Some factors, such as sample adequacy, 
superinfection, fibrosis, clinical and 
radiology information, pathologist 
experience in interpreting cytological 
specimens, and staining methods may 
affect the diagnostic value of FNAB. 
Although this study only used data from 
FNAB without imaging guide, ancillary 
modalities (USG or CT-scan) may be used 
to improve sample adequacy. Complete 
clinical and imaging information along 
with experiences in accurate cytological 
interpretation are crucial to support 
pathologists in establishing a reliable 
diagnosis.
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